Clinical Trials Logo

Clinical Trial Summary

Carbapenem resistance is a high mortality rate of Klebsiella pneumoniae infection. It has been proved that high-dose carbapenem can reduce mortality and has a certain clinical effect. In this study, a high dose of biapenem was compared to determine whether it had a similar effect than meropenem.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT04552444
Study type Observational
Source Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact Man Huang, Ph D
Phone +8613685753994
Status Recruiting
Start date June 1, 2019
Completion date August 1, 2021